Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.47 |
| ▸ | MPO | P05164 | 2/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | TLR8 | Q9NR97 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17537993 | 0.98 | MAOA (0.50) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537736 | 0.98 | MAOA (0.54) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537722 | 0.95 | MAOA (0.52) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537990 | 0.95 | MAOA (0.52) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537720 | 0.95 | CHEK1 (0.47) | MAOASLC6A4MPOCHEK1TLR8 | |
| SCHEMBL17537731 | 0.93 | MAOA (0.50) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537725 | 0.91 | MAOA (0.48) | MAOASLC6A4MPOHRH1CYP1A2 | |
| SCHEMBL17537724 | 0.91 | MAOA (0.48) | MAOASLC6A4MPOCHEK1HRH1 | |
| SCHEMBL17537740 | 0.91 | TAAR1 (0.47) | MAOASLC6A4MPOCHEK1CYP1A2 | |
| SCHEMBL17537737 | 0.90 | MAOA (0.47) | MAOASLC6A4MPOCHEK1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2018-04-05 | — | — | US | disclosed |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2017-08-17 | — | — | US | disclosed |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2017-08-17 | — | — | US | disclosed |
| WO-2016022943-A2 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2016-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | MAOA 3608/4885SLC6A4 4851/4885MPO 1014/4885 |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | MAOA 3608/4885SLC6A4 4851/4885MPO 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.